SymbioPharm GmbH
- Address
- Auf Den Lueppen 10, Hoerbach
Sponsor Overview
Specializations
Irritable Bowel Syndrome
Research activity is centred on irritable bowel syndrome, with particular attention to the diarrhoea-predominant form (IBS-D) and its burden of persistent gastrointestinal symptoms.
- IBS-D symptom control
- Frequency and severity of bowel symptoms
- Gastrointestinal tolerability
The sponsor’s clinical interest in this area is focused on oral treatment approaches for patients with functional bowel disorders.
Microbiome-Related Gastrointestinal Therapy
The trial portfolio includes work on a live bacterial oral product for gastrointestinal symptom management, reflecting interest in microbiome-based therapy for functional digestive conditions.
- Live bacterial therapy
- Oral gastrointestinal treatment
- Functional bowel disorder support
This area aligns with therapeutic development for symptoms associated with altered bowel function and digestive discomfort.
Safety and Tolerability
Clinical interest extends to the assessment of safety and tolerability in patients receiving treatment for chronic digestive symptoms.
- Safety profile evaluation
- Tolerability in IBS-D
- Patient treatment acceptability
These topics are relevant to the clinical use of therapies intended for ongoing management of functional bowel symptoms.
Multicentre Clinical Research
The sponsor’s research footprint includes collaboration across multiple sites in Germany, supporting clinical evaluation in a real-world patient population with IBS.
- Multi-site patient recruitment
- Gastroenterology-focused collaboration
- Clinical assessment in adult IBS populations
Current activity is concentrated on a single recruiting study within the field of digestive health.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Efficacy and Safety of Escherichia coli DSM 17252 in Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |  Germany | Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 31 sites across their trial portfolio.
Therapeutic Focus
- 1.Digestive System Diseases1 trial280 other sponsors
- 2.Immune System Diseases1 trial322 other sponsors
- 3.Nutritional and Metabolic Diseases1 trial211 other sponsors
Partnered Research Centres
31 centres- Address
- Wilhelm-Leuschner-Platz 12, Zentrum-Süd, 04107 Leipzig
- Address
- Weissenseer Weg 111, Lichtenberg, 10369 Berlin
- Address
- Johannes-Lange-Str. 20, 39319 Jerichow
- Address
- Im Pruefling 21-25, Bornheim, 60389 Frankfurt
- Address
- Kurze Str. 7, 04683 Naunhof
- Address
- Horster Strasse 137, Butendorf, 45968 Gladbeck
Want to get in touch with this sponsor?
Send a question and we'll pass it on to SymbioPharm GmbH.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.